Immunotherapies for cancer -- treatments that prime the immune system to attack tumors -- are valuable weapons in the anti-cancer arsenal. But some cancers are more difficult to target with this strategy than others. Today, scientists report a new immunotherapy that dramatically extends the survival of mice that have triple negative breast tumors, a difficult-to-treat form of cancer.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/08/200817104327.htm
No comments:
Post a Comment